Health For Each Health For Each
bone cancer cells Employees Health Benefits KFF Health Information Cantor Global Healthcare KFF Health public health experts C-reactive protein

Cantor Global Healthcare


Hospital mergers and acquisitions rarely improve health care value or reduce prices

Hospital mergers and acquisitions rarely improve health care value or reduce prices

A Systematic Review of Integration Strategies Across the U.S. Healthcare System Shows No Consistent Improvement in Price, Cost Reduction, or Quality of Care.


Fine particulate air pollution may play a role in adverse birth outcomes

Fine particulate air pollution may play a role in adverse birth outcomes

For pregnant women, exposure to fine particulate air pollution (PM2.5) was associated with altered immune responses that can lead to adverse birth outcomes, according to a new study led by Harvard T.H.


Climate change and eye maladies

Climate change and eye maladies

Patnaik said the health risks of air pollution and climate change span a wide range of outcomes including infectious disease, weather-related morbidity and a variety of lung, kidney and cardiovascular maladies.


Researchers show why cannabis policies should shift to a harm reduction, health promotion approach to safeguard public health

Researchers show why cannabis policies should shift to a harm reduction, health promotion approach to safeguard public health

July 6, 2022 — A group of public health experts from several universities and organizations is urging adoption of a multi-layered approach when developing policies to mitigate the impact of gas and oil production ...


Cheap Ozempic is coming: Cost could soon be slashed for millions of Americans, drugmaker confirms — here’s how

Cheap Ozempic is coming: Cost could soon be slashed for millions of Americans, drugmaker confirms — here’s how

Ulrich Otte, the company’s senior vice president of finance and operations, made the claim at the Cantor Global Healthcare Conference in New York earlier this week, saying: “It is very likely that Ozempic will be part of negotiations in the coming round, and we’re ready for that.”